3 Patents
- US125706712026Substituted Oxoisoindoline Compounds for the Treatment of Cancer
Bristol-myers Squibb Company
0 cites - 0 cites
- US116492122023Inhibitors of Indoleamine 2,3-dioxygenase and Methods of Their Use
Bristol-myers Squibb Company
0 cites